Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Todd McLaughlin, Grant Wang, Andy Medina, Jacob Perkins, Rhudwan Nihlawi, Don Seyfried, Zihua Hu, Joshua J Wang, Sarah X Zhan. Essential Role of XBP1 in Maintaining Photoreceptor Synaptic Integrity in Early Diabetic Retinopathy. Investigative ophthalmology & visual science. vol 64. issue 14. 2023-11-28. PMID:38015176. |
diabetic retinopathy (dr) is a leading cause of blindness in working-age adults characterized by retinal dysfunction and neurovascular degeneration. |
2023-11-28 |
2023-11-29 |
Not clear |
Saket Y Maheshwari, Sunil Kumar, Arya Harshyt Sinha, Mayank Kuma. Diabetic Retinopathy: A Pharmacological Consideration. Cureus. vol 15. issue 10. 2023-11-13. PMID:37954772. |
one of the most significant reasons for the manifestation of new cases of complete blindness may be attributed to dr. |
2023-11-13 |
2023-11-20 |
human |
Liu Li, Yu Jin, Jun Hua Wang, Sha Sha Wang, Fang Xiu Yua. Potency of teleophthalmology as a detection tool for diabetic retinopathy. Scientific reports. vol 13. issue 1. 2023-11-10. PMID:37949948. |
the purpose of this study was to use the results of ophthalmologists as the gold standard to evaluate the accuracy of community general practitioners' judgement and grading of dr to find a feasible and convenient dr screening method to reduce the risk of visual impairment and blindness in known diabetes patients. |
2023-11-10 |
2023-11-20 |
Not clear |
Thokozani Zungu, Shaffi Mdala, Petros Kayange, Elizabeth Fernando, Halima Twabi, Arnold Jumbe, Johnstone Kumwenda, Adamson Muul. Uptake of diabetic retinopathy screening at a secondary level facility in Malawi. PLOS global public health. vol 3. issue 11. 2023-11-08. PMID:37939026. |
dr screening is a cost-effective intervention for preventing blindness from dr. we conducted a cross-sectional study to investigate the uptake and the predictors of uptake of annual dr screening in an opportunistic dr screening programme at a secondary-level diabetes clinic in southern malawi. |
2023-11-08 |
2023-11-20 |
human |
Yanqiu Liu, Zifan Xu, Haohan Zheng, Jiahui Yang, Meili Wu, Qian Yang, Yan Wang, Tianyi Zong, Xusheng Yang, Tianhua Xie, Jiping Cai, Yong Yao, Xiaolu Wan. MiR-423-5p promotes M\\xc3\\xbcller cell activation via targeting NGF signaling in diabetic retinopathy. Life sciences. 2023-11-04. PMID:37925140. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus and one of the major causes of visual impairment and blindness in industrialized countries. |
2023-11-04 |
2023-11-08 |
mouse |
Jufen Liu, Huijing Wang, Cuiting Huan. Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy Archives of physiology and biochemistry. 2023-11-03. PMID:37920998. |
exendin-4, a glp-1 receptor agonist, suppresses diabetic retinopathy diabetic retinopathy (dr) is a complication of diabetes and a leading cause of blindness in adults. |
2023-11-03 |
2023-11-08 |
rat |
Posham Uppamma, Sweta Bhattachary. A multidomain bio-inspired feature extraction and selection model for diabetic retinopathy severity classification: an ensemble learning approach. Scientific reports. vol 13. issue 1. 2023-10-31. PMID:37903967. |
diabetes retinopathy (dr) is one of the leading causes of blindness globally. |
2023-10-31 |
2023-11-08 |
Not clear |
Taif F Alqahtani, Rahaf Alqarehi, Oyoon M Mulla, Asayel T Alruwais, Shajn S Alsaadi, Hajar Algarni, Yaser M Elhams, Safa Alkalas. Knowledge, Attitude, and Practice Regarding Diabetic Retinopathy Screening and Eye Management Among Diabetics in Saudi Arabia. Cureus. vol 15. issue 9. 2023-10-31. PMID:37905261. |
background globally, one of the leading causes of blindness is diabetic retinopathy (dr). |
2023-10-31 |
2023-11-08 |
human |
Pedro Romero-Aroca, Raquel Verges, Jordi Pascual-Fontanilles, Aida Valls, Josep Franch, Joan Barrot, Xavier Mundet, Alex La Torre, Antonio Moreno, Ramon Sagarra, Josep Basora, Eugeni Garcia-Curto, Marc Baget-Bernaldi. Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients after 10 Years of Follow-Up. Journal of clinical medicine. vol 12. issue 20. 2023-10-30. PMID:37892811. |
(1) background: diabetic retinopathy (dr) remains the leading cause of low vision and blindness in young adults of working age. |
2023-10-30 |
2023-11-08 |
Not clear |
Brenda F M Castro, Jason C Steel, Christopher J Layto. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2023-10-25. PMID:37878215. |
age-related macular degeneration (amd) and diabetic retinopathy (dr) are vascular diseases with high prevalence, ranking among the leading causes of blindness and vision loss worldwide. |
2023-10-25 |
2023-11-08 |
Not clear |
Lili Zhao, Qingmin Pa. Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Translational vision science & technology. vol 12. issue 10. 2023-10-24. PMID:37856104. |
diabetic retinopathy (dr) is the leading cause of blindness in patients with diabetes mellitus (dm). |
2023-10-24 |
2023-11-08 |
Not clear |
Anza Rizvi, Fatima Rizvi, Parth Lalakia, Leslie Hyman, Rosemary Frasso, Les Sztandera, Anthony Vipin Da. Is Artificial Intelligence the Cost-Saving Lens to Diabetic Retinopathy Screening in Low- and Middle-Income Countries? Cureus. vol 15. issue 9. 2023-10-24. PMID:37868419. |
the emergence of diabetes as a global pandemic is one of the major challenges to human health, as long-term microvascular complications such as diabetic retinopathy (dr) can lead to irreversible blindness. |
2023-10-24 |
2023-11-08 |
human |
Ahlam Shamsan, Ebrahim Mohammed Senan, Hamzeh Salameh Ahmad Shatnaw. Predicting of diabetic retinopathy development stages of fundus images using deep learning based on combined features. PloS one. vol 18. issue 10. 2023-10-20. PMID:37862328. |
therefore, regular diagnosis of diabetes patients is necessary to avoid the progression of dr stages to advanced stages that lead to blindness. |
2023-10-20 |
2023-11-08 |
Not clear |
Muhammad Zulfiqah Sadikan, Nurul Alimah Abdul Nasir, Lidawani Lambuk, Rohimah Mohamud, Nur Hidayah Reshidan, Evon Low, Saiful Anuar Singar, Awis Sukarni Mohmad Sabere, Igor Iezhitsa, Renu Agarwa. Diabetic retinopathy: a comprehensive update on in vivo, in vitro and ex vivo experimental models. BMC ophthalmology. vol 23. issue 1. 2023-10-19. PMID:37858128. |
diabetic retinopathy (dr), one of the leading causes of visual impairment and blindness worldwide, is one of the major microvascular complications in diabetes mellitus (dm). |
2023-10-19 |
2023-11-08 |
Not clear |
Rita Vought, Victoria Vought, Megh Shah, Bernard Szirth, Neelakshi Bhaga. EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events. International ophthalmology. 2023-10-17. PMID:37847478. |
early detection and treatment of diabetic retinopathy (dr) are critical for decreasing the risk of vision loss and preventing blindness. |
2023-10-17 |
2023-11-08 |
Not clear |
Qionghua Wang, Lanyue Zhang, Qiang Shen, Chunqin Zeng, Yanhong Fang, Kepeng O. 5-Bromo-3,4-dihydroxybenzaldehyde stabilizes diabetic retinal neurovascular units by inhibiting the inflammatory microenvironment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 168. 2023-10-15. PMID:37839106. |
diabetic retinopathy (dr) is a leading cause of blindness characterized by damage to the retinal neurovascular unit, which is caused by hyperglycemia-induced metabolic and inflammatory responses. |
2023-10-15 |
2023-11-08 |
Not clear |
Mohammed Arif Iftakher Mahmood, Nasrin Aktar, Md Fazlul Kade. A hybrid approach for diagnosing diabetic retinopathy from fundus image exploiting deep features. Heliyon. vol 9. issue 9. 2023-10-09. PMID:37809795. |
one of the major causes of blindness in human beings is the diabetic retinopathy (dr). |
2023-10-09 |
2023-10-15 |
human |
S Umar Hasan, M A Rehman Siddiqu. Diagnostic accuracy of smartphone-based artificial intelligence systems for detecting diabetic retinopathy: a systematic review and meta-analysis. Diabetes research and clinical practice. 2023-10-07. PMID:37805002. |
diabetes retinopathy(dr) is a major cause of blindness globally, early detection is critical to prevent vision loss. |
2023-10-07 |
2023-10-15 |
human |
Hong-Dian Li, Ming-Xuan Li, Wen-Hua Zhang, Shu-Wen Zhang, Yan-Bing Gon. Effectiveness and safety of traditional Chinese medicine for diabetic retinopathy: A systematic review and network meta-analysis of randomized clinical trials. World journal of diabetes. vol 14. issue 9. 2023-09-29. PMID:37771328. |
diabetic retinopathy (dr) is currently recognized as one of the most serious diabetic microangiopathies and a major cause of adult blindness. |
2023-09-29 |
2023-10-07 |
Not clear |
Hang Hyo Jo, Yeong Seok Goh, Hye Jih Kim, Dae Hyun Kim, Hyemin Kim, Jiyi Hwang, Ji Seung Jung, Nanyoung Kang, Sang Eun Park, Kyung Mee Park, Hyun Jik Le. Tacrolimus Improves Therapeutic Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Diabetic Retinopathy by Suppressing DRP1-Mediated Mitochondrial Fission. Antioxidants (Basel, Switzerland). vol 12. issue 9. 2023-09-28. PMID:37760030. |
diabetic retinopathy (dr) is a leading cause of blindness in diabetic patients. |
2023-09-28 |
2023-10-07 |
rat |